OPPI Head On Sustaining Supplies In India During The Pandemic

OPPI director general and ex-MSD India chief outlines how pharma in India is ensuring medicines reach patients amid COVID-19, working closely with various stakeholders. De-risking the supply chain and up-skilling sales forces in view of widespread digital engagement are among the key issues firms are addressing.

India
Pharma In India Working With Stakeholders To Maintain Supplies • Source: Shutterstock

Industry veteran K G Ananthakrishnan took charge earlier this year as director general of the Organization of Pharmaceutical Producers of India (OPPI), which represents foreign drug firms in the country, amid disruption across pharma’s operations as a result of the raging coronavirus pandemic. 

The former vice-president and managing director, South Asia Region for MSD India, set the agenda at the industry body at...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from India

More from Focus On Asia